Organon & Co (United States) is listed on the Nasdaq and has a market capitalization of $3.56 billion, with shareholders equity totaling $903.00 Thousand.
The Company is listed on the [MARKET_NAME]
Over the past 12 months, Organon & Co reported $4.57 billion in revenue, generating net income of $14.23 million.
Key financial metrics include a P/E ratio of 250.11, a price-to-book (P/B) ratio of 3,941.98, and a trailing twelve-month dividend yield of 0.59%.
The company trades under the ticker OGN.